Predictors of Hospital Mortality in the Global Registry of Acute Coronary Events

Archives of Internal Medicine

Volumn 163, Issue 19, 2003, Pages 2345-2353

  Granger, Christopher B ^a,j   Goldberg, Robert J ^b   Dabbous, Omar ^b   Pieper, Karen S ^a   Eagle, Kim A ^c   Cannon, Christopher P ^d   Van de Werf, Frans ^e   Avezum, Álvaro ^f   Goodman, Shaun G ^g   Flather, Marcus D ^h   Fox, Keith A A ⁱ  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^g ST MICHAEL'S HOSPITAL   (Canada)

^h ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

^j DUKE CLINICAL RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DATA BASE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGISTER; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION;

AGED; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 0041353672     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.19.2345     Document Type: Article

References (38)

1. American Heart Association 2001 heart and stroke statistical update. Available at: http://www.americanheart.org/statistics/pdf/HSSTATS2001_1.0.pdf. Accessed December 2, 2001.
2. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269-1276.
3. Braunwald E, Antman EM, Beasley, JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report ofthe American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) [published erratum appears in J Am Coll Cardiol. 2001;38:294-295]. J Am Coll Cardiol. 2000;36:970-1062.
4. Braunwald E, Antman EM, Beasley, JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report ofthe American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) [published erratum appears in J Am Coll Cardiol. 2001;38:294-295]. J Am Coll Cardiol. 2000;36:970-1062.
5. Ryan TJ, Antman EM, Brooks NH, et al. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1999;34:890-911.
6. Antman EM, Cohen M, Bernink PJLM, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835-842.
7. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation: recommendations of the Task Force of the European Society of Cardiology. Eur Heart J. 2000;21:1406-1432.
8. Collinson J, Flather MD, Fox KA, et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J. 2000;21:1450-1457.
9. Lee KL, Woodlief LH, Topol EJ, et al, for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41021 patients. Circulation. 1995;91:1659-1668.
10. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial substudy. Circulation. 2000;102:2031-2037.
11. Morrow DA, Antman EM, Giugliano RP, et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an In TIME II substudy. Lancet. 2001;358:1571-1575.
12. Krumholz HM, Chen J, Wang Y, Radford MJ, Chen YT, Marciniak TA. Comparing AMI mortality among hospitals in patients 65 years of age and older: evaluating methods of risk adjustment. Circulation. 1999;99:2986-2992.
13. Boersma E, Pieper KS, Steyerberg EW, et al, for the PURSUIT Investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients. Circulation. 2000;101:2557-2567.
14. Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999;281:707-713.
15. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L, for the FRISC Study Group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease: Fragmin during Instability in Coronary Artery Disease. N Engl J Med. 2000;343:1139-1147.
16. Jollis JG. Measuring the effectiveness of medical care delivery. J Am Coll Cardiol. 2001;37:998-1000.
17. The GRACE Investigators. GRACE: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141:190-199.
18. Tunstall Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
19. WHO MONICA project: objectives and design. Int J Epidemiol. 1989;18(suppl 1):S29-S37.
20. Schafer JL. Analysis of Incomplete Multivariate Data. New York, NY: Chapman & Hall; 1997.
21. Harrell FE Jr. Predicting Outcomes: Applied Survival Analysis and Logistic Regression. Charlottesville: University of Virginia; 1998.
22. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1993.
23. SAS STATUser's Guide, Version 8. Cary, NC: SAS Institute; 1999:1903-2042.
24. MathSoft. S-Plus User's Manual, Version 3.4. Seattle, Wash: MathSort Inc; 1996.
25. Califf RM, Woodlief LH, Harrell FE Jr, et al, for the GUSTO-I Investigators. Selection of thrombolytic therapy for individual patients: development of a clinical model. Am Heart J. 1997;133:630-639.
26. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med. 1996;335:775-782.
27. Muller DW, Topol EJ. Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med. 1990;113:949-960.
28. Morrow DA, Antman EM, Parsons L, et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001;286:1356-1359.
29. Ohman EM, Granger CB, Harrington RA, Lee KL. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA. 2000;284:876-878.
30. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
31. InTIME-II Investigators. Intravenous NPA for the Treatment of Infarcting Myocardium Early: InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J. 2000;21:2005-2013.
32. Rao V, Weisel RD, Buth KJ, et al. Coronary artery bypass grafting in patients with non-dialysis-dependent renal insufficiency. Circulation. 1997;96(9 suppl):II-38-II-43.
33. Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974-980.
34. Marchioli R, Avanzini F, Barzi F, et al, on behalf of GISSI-Prevenzione Investigators F. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-prevenzione mortality risk chart. Eur Heart J. 2001;22:2085-2103.
35. Ohman EM, Armstrong PW, Christenson RH, et al, for the GUSTO IIA Investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333-1341.
36. Heeschen C, Hamm CW, Bruemmer J, Simoons ML, for the CAPTURE Investigators. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis: Chimeric c7E3 Antiplatelet Therapy in Unstable Angina Refractory to Standard Treatment Trial. J Am Coll Cardiol. 2000;35:1535-1542.
37. Hamm CW, Heeschen C, Goldmann B, et al, for the c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med. 1999;340:1623-1629.
38. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. JAMA. 2001;286:2107-2113.